Amador Bioscience

About Amador Bioscience

Amador Bioscience is a full-service Contract Research Organization (CRO) that specializes in drug development. They provide comprehensive services from preclinical research to Clinical Phase IV studies, serving pharmaceutical companies and other businesses in the healthcare sector. Operating in a global market, they have a presence in several locations including California, Maryland, Michigan, Virginia, Belgium, Hangzhou, Shanghai, and Beijing.

Their business model revolves around providing a bridge from early research to approval in drug development programs. They offer a range of services including bioanalysis, biomarker services, clinical pharmacology, regulatory affairs, and clinical research services. These services are designed to improve the success of Investigational New Drugs (INDs), a term used for a new pharmaceutical product not yet approved by the FDA for sale in the market.

Amador Bioscience makes money by charging clients for these services. They aim to reduce risk in drug development, save time and money for their clients, and increase the chances of INDs getting approved. Their approach is tailored to each client's needs, offering both global expertise and local solutions.

In summary, Amador Bioscience is a global CRO that offers a wide range of services to support drug development, from early research to approval, with the goal of improving the success rate of INDs while saving time and money for their clients.